56 research outputs found

    Online Cooperative Promotion and Cost Sharing Policy under Supply Chain Competition

    Get PDF
    This paper studies online cooperative promotion and cost sharing decisions in competing supply chains. We consider a model of one B2C e-commerce platform and two supply chains each consisting of a supplier and an online retailer. The problem is studied using a multistage game. Firstly, the e-commerce platform carries out the cooperative promotion and sets the magnitude of markdown (the value of e-coupon). Secondly, each retailer and his supplier determine the fraction of promotional cost sharing when they have different bargaining power. Lastly, the retailers decide whether to participate in the cooperative promotion campaign. We show that the retailers are likely to participate in the promotion if consumers become more price-sensitive. However, it does not imply that the retailers can benefit from the price promotion; the promotion decision game resembles the classical prisoner’s dilemma game. The retailers and suppliers can benefit from the cooperative promotion by designing an appropriate cost sharing contract. For a supply chain, the bargaining power between supplier and retailer, consumer price sensitivity, and competition intensity affect the fraction of the promotional cost sharing. We also find that equilibrium value of e-coupon set by the e-commerce platform is not optimal for all the parties

    Leukotriene B4 receptor knockdown affects PI3K/AKT/mTOR signaling and apoptotic responses in colorectal cancer

    Get PDF
    Colorectal cancer (CRC) presents a landscape of intricate molecular dynamics. In this study, we focused on the role of the leukotriene B4 receptor (LTB4R) in CRC, exploring its significance in the disease's progression and potential therapeutic approaches. Using bioinformatics analysis of the GSE164191 and the Cancer Genome Atlas-colorectal adenocarcinoma (TCGA-COAD) datasets, we identified LTB4R as a hub gene influencing CRC prognosis. Subsequently, we examined the relationship between LTB4R expression, apoptosis, and the phosphoinositide 3-kinase/protein kinase B/mammalian target of rapamycin (PI3K/AKT/mTOR) signaling pathway through cellular and mice experiments. Our findings revealed that LTB4R is highly expressed in CRC samples and is pivotal for determining prognosis. In vitro experiments demonstrated that silencing LTB4R significantly impeded CRC cell viability, migration, invasion, and colony formation. Correspondingly, in vivo tests indicated that LTB4R knockdown led to markedly slower tumor growth in mice models. Further in-depth investigation revealed that LTB4R knockdown significantly amplified the apoptosis in CRC cells and upregulated the expression of apoptosis-related proteins, such as caspase-3 and caspase-9, while diminishing p53 expression. Interestingly, silencing LTB4R also resulted in a significant downregulation of the PI3K/AKT/mTOR signaling pathway. Moreover, pretreatment with the PI3K activator 740Y-P only partially attenuated the effects of LTB4R knockdown on CRC cell behavior, emphasizing LTB4R's dominant influence in CRC cell dynamics and signaling pathways. LTB4R stands out as a critical factor in CRC progression, profoundly affecting cellular behavior, apoptotic responses, and the PI3K/AKT/mTOR signaling pathway. These findings not only shed light on LTB4R's role in CRC but also establish it as a potential diagnostic biomarker and a promising target for therapeutic intervention

    Branch-and-reduce algorithm for convex programs with additional multiplicative constraints

    No full text
    This article presents a branch-and-reduce algorithm for globally solving for the first time a convex minimization problem (P) with p[greater-or-equal, slanted]1 additional multiplicative constraints. In each of these p additional constraints, the product of two convex functions is constrained to be less than or equal to a positive number. The algorithm works by globally solving a 2p-dimensional master problem (MP) equivalent to problem (P). During a typical stage k of the algorithm, a point is found that minimizes the objective function of problem (MP) over a nonconvex set Fk that contains the portion of the boundary of the feasible region of the problem where a global optimal solution lies. If this point is feasible in problem (MP), the algorithm terminates. Otherwise, the algorithm continues by branching and creating a new, reduced nonconvex set Fk+1 that is a strict subset of Fk. To implement the algorithm, all that is required is the ability to solve standard convex programming problems and to implement simple algebraic steps. Convergence properties of the algorithm are given, and results of some computational experiments are reported.Global optimization Multiplicative programming Product of convex functions Branch-and-reduce

    Dynamic Model Selection Based on Demand Pattern Classification in Retail Sales Forecasting

    No full text
    Many forecasting techniques have been applied to sales forecasts in the retail industry. However, no one prediction model is applicable to all cases. For demand forecasting of the same item, the different results of prediction models often confuse retailers. For large retail companies with a wide variety of products, it is difficult to find a suitable prediction model for each item. This study aims to propose a dynamic model selection approach that combines individual selection and combination forecasts based on both the demand patterns and the out-of-sample performance for each item. Firstly, based on both metrics of the squared coefficient of variation (CV2) and the average inter-demand interval (ADI), we divide the demand patterns of items into four types: smooth, intermittent, erratic, and lumpy. Secondly, we select nine classical forecasting methods in the M-Competitions to build a pool of models. Thirdly, we design two dynamic weighting strategies to determine the final prediction, namely DWS-A and DWS-B. Finally, we verify the effectiveness of this approach by using two large datasets from an offline retailer and an online retailer in China. The empirical results show that these two strategies can effectively improve the accuracy of demand forecasting. The DWS-A method is suitable for items with the demand patterns of intermittent and lumpy, while the DWS-B method is suitable for items with the demand patterns of smooth and erratic

    Predictive Value of Two Polymorphisms of ERCC2, rs13181 and rs1799793, in Clinical Outcomes of Chemotherapy in Gastric Cancer Patients: A Meta-Analysis

    No full text
    Background. Several researchers have investigated the relationship between ERCC2 rs13181 and rs1799793 polymorphisms and chemotherapy efficacy in terms of tumour response and prognosis in gastric patients. However, the published data have shown inconsistencies. Methods. PubMed, Elsevier, and Chinese National Knowledge Infrastructure databases were searched for relevant articles published before August 1, 2017. Thirteen studies including 3096 gastric cancer patients treated with chemotherapy were included. Results. For rs1799793, in the overall analyses, no relationships were found between four genetic models and clinical response (AA vs. GG: OR = 1.17, 95% CI, 0.70–1.95; GA vs. GG: OR = 0.94, 95% CI, 0.69–1.27; GA + AA vs. GG: OR = 1.12, 95% CI, 0.85–1.46; and AA vs. GG + GA: OR = 1.24, 95% CI, 0.81–1.92). In stratified analyses, the results remained negative. We also found no relationship between each of the genetic models and overall survival time in the overall analyses. In the stratified analyses, for Asians, the A carrier genotype might be more closely associated with shorter survival time and higher risk of death for patients than the GG genotype (AA vs. GG: HR = 1.77, 95% CI, 1.20–2.6; GA + AA vs. GG: HR = 1.62, 95% CI, 1.26–2.09), but the results were negative for Caucasians. No significant relationships were found between the rs13181 polymorphism and OR or OS. Conclusions. This meta-analysis suggested that the ERCC2 rs1799793 polymorphism might be a predictor of prognosis in gastric cancer patients subjected to platinum-based chemotherapy
    • …
    corecore